EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

A Comprehensive Meta‐Analysis of Bioadaptor Versus Drug‐Eluting Stents in Randomised Trials With Exploratory Single‐Arm Landmark Analyses

Simon Wölbert iD, Stephanie Kühne iD, Andrea Patrignani iD, Mauro Chiarito iD, Moritz von Scheidt, Jan Torzewski iD, Philip Raake, Dario Bongiovanni iD

European Journal of Clinical Investigation · 2026-05 · 56 (5)

DOI: 10.1111/eci.70217 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 05.05.2026. Verfasst von Simon Wölbert und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Cardiology, University Hospital Augsburg, University of Augsburg, Augsburg, Germany. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Percutaneous Coronary Intervention, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Late adverse events after percutaneous coronary intervention continue to occur beyond the first year with last‐generation drug‐eluting stents (DES). The coronary bioadaptor marks a new approach with an uncaging beginning at approximately 6 months after implantation. We conducted a pairwise meta‐analysis of bioadaptor versus DES in randomised trials with complementary single‐arm 6–12 and 6–24 landmark analyses.

Methods

The systematic review and meta‐analysis was conducted according to PRISMA 2020 Guidelines. PubMed, Embase, CENTRAL and Google Scholar were searched for studies reporting clinical outcomes after bioadaptor implantation. The primary outcome was target‐lesion failure (TLF), a composite of cardiac death, target‐vessel myocardial infarction and target‐lesion revascularisation at 1 year. Secondary outcomes were TLF and individual components at landmark intervals 6–12 and 6–24 months. Single‐arm pooled event rates and pairwise comparisons were estimated using generalised linear mixed‐effects models.

Results

Three randomised trials ( n = 2892; 1448 bioadaptor, 1444 DES) were included in pairwise analyses. 1‐year TLF showed no significant difference between bioadaptor and DES (OR 0.81, 95% CI 0.51–1.31, I 2 = 0.0%, p = 0.3943). Likewise, individual components of TLF and device thrombosis did not differ between groups. Ten studies (1753 patients; 1900 lesions) were included in single‐arm analyses. Landmark TLF was 0.57% (95% CI 0.07–4.29; I 2 = 4.6%) from 6 to 12 months and 2.01% (95% CI 0.81–4.92; I 2 = 74.2%) from 6 to 24 months. Event rates for other endpoints were generally low.

Conclusions

No significant differences in safety and efficacy outcomes were observed between bioadaptor and DES. Complementary single‐arm landmark analyses suggested low late event rates, but these findings should be interpreted as exploratory. Further randomised trials are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsPercutaneous Coronary InterventionCoronary Artery DiseaseHumansRandomized Controlled Trials as TopicMyocardial Infarction

Stichwörter der Autor:innen

bioadaptordrug‐eluting stentsmeta‐analysispercutaneous coronary interventionrandomised controlled trialstarget‐lesion failure

Autor:innen und Institutionen

  • Department of Internal Medicine I, Cardiology, University Hospital Augsburg, University of Augsburg, Augsburg, Germany.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Humanitas Research Hospital IRCCS, Milano, Italy.
  • Department of Cardiology, German Heart Center, TUM University Hospital, Technical University Munich, Munich, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
  • Cardiovascular Center Oberallgäu-Kempten, Kempten, Germany.

ORCID-Profile: Simon Wölbert, Stephanie Kühne, Andrea Patrignani, Mauro Chiarito, Jan Torzewski, Dario Bongiovanni

Zitieren

APA

Wölbert, S., Kühne, S., Patrignani, A., Chiarito, M., von Scheidt, M., Torzewski, J., Raake, P., & Bongiovanni, D. (2026). A Comprehensive Meta‐Analysis of Bioadaptor Versus Drug‐Eluting Stents in Randomised Trials With Exploratory Single‐Arm Landmark Analyses. European Journal of Clinical Investigation, 56(5). https://doi.org/10.1111/eci.70217

Vancouver

Wölbert S, Kühne S, Patrignani A, Chiarito M, von Scheidt M, Torzewski J, et al. A Comprehensive Meta‐Analysis of Bioadaptor Versus Drug‐Eluting Stents in Randomised Trials With Exploratory Single‐Arm Landmark Analyses. European Journal of Clinical Investigation. 2026;56(5). doi:10.1111/eci.70217

BibTeX
@article{Wlbert2026,
  author = {Wölbert, Simon and Kühne, Stephanie and Patrignani, Andrea and Chiarito, Mauro and von Scheidt, Moritz and Torzewski, Jan and Raake, Philip and Bongiovanni, Dario},
  title = {A Comprehensive Meta‐Analysis of Bioadaptor Versus Drug‐Eluting Stents in Randomised Trials With Exploratory Single‐Arm Landmark Analyses},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  volume = {56},
  number = {5},
  doi = {10.1111/eci.70217}
}
Kostenlos starten →